ICD can enhance adjuvanticity and antigenicity from dying cancer cells by releasing damage-associated molecular patterns (DAMPs), including calreticulin (CRT), high mobility group box 1 (HMGB1), and adenosine triphosphate (ATP) 44. The gene discussed is HMGB1; the disease is cancer.